Cathepsin K Inhibitors

被引：3
|
作者：
Black, W. Cameron [1 ]
Percival, M. David [1 ]
机构：
[1] Merck Frosst Ctr Therapeut Res, Kirkland, PQ H9H 3L1, Canada
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42008-5
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：111 / 127
页数：17
相关论文
共 50 条
  • [31] New cathepsin K inhibitors containing argininal thiosemicarbazones
    Yeramala, Durga
    Guda, Bharat
    Akula, Prashanth
    Tha, Soe
    Rahman, Franklin
    Kadasala, Naveen Reddy
    Malayala, Karthik
    Jin, Jin
    Zhang, Shaozhong
    Wen, Lisa
    Huang, Jenq-Kuen
    McConnell, Rose M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [32] Cathepsin K Inhibitors Isolated from Ginger Rhizome
    James Almada da Silva
    Caio Yu dos Santos
    Mohadese Mohammadi
    João Batista Fernandes
    Maria Fátima das Graças Fernandes da Silva
    Paulo Cezar Vieira
    Revista Brasileira de Farmacognosia, 2021, 31 : 859 - 864
  • [33] Bone effects of cathepsin K inhibitors in the growing rabbit
    Pennypacker, B.
    Rodan, S.
    Rodan, G.
    Black, C.
    Oballa, R.
    Wehren, Lois E.
    Kimmel, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S194 - S195
  • [34] Cathepsin K inhibitors: A novel target for osteoporosis therapy
    Stoch, S. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 172 - 176
  • [35] Acyclic cyanamide-based inhibitors of cathepsin K
    Barrett, DG
    Deaton, DN
    Hassell, AM
    McFadyen, RB
    Miller, AB
    Miller, LR
    Payne, JA
    Shewchuk, LM
    Willard, DH
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3039 - 3043
  • [36] Bone effects of cathepsin K inhibitors in the growing rabbit
    Pennypacker, B.
    Rodan, S.
    Rodan, G.
    Black, C.
    Oballa, R.
    Wehren, L.
    Kimmel, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S117 - S118
  • [37] In Search of Selective Inhibitors of Cysteine Protease, Cathepsin K
    Ewa Wieczerzak
    Piotr Drabik
    Magnus Abrahamson
    Anders Grubb
    International Journal of Peptide Research and Therapeutics, 2005, 11 : 203 - 209
  • [38] Structure and design of potent and selective cathepsin K inhibitors
    Yamashita, DS
    Smith, WW
    Zhao, BG
    Janson, CA
    Tomaszek, TA
    Bossard, MJ
    Levy, MA
    Oh, HJ
    Carr, TJ
    Thompson, SK
    Ijames, CF
    Carr, SA
    McQueney, M
    DAlessio, KJ
    Amegadzie, BY
    Hanning, CR
    AbdelMeguid, S
    DesJarlais, RL
    Gleason, JG
    Veber, DF
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) : 11351 - 11352
  • [39] Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis
    Ginnetti, Anthony T.
    Paone, Daniel, V
    Nanda, Kausik K.
    Li, Jing
    Busuek, Marina
    Johnson, Scott A.
    Lu, Jun
    Soisson, Stephen M.
    Robinson, Ronald
    Fisher, John
    Webber, Andrea
    Wesolowski, Gregg
    Ma, Bennett
    Le Duong
    Carroll, Steven
    Burgey, Christopher S.
    Stachel, Shawn J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 74
  • [40] Orally Bioavailable Cathepsin K Inhibitors with Pyrrolopyrimidine Scaffold
    Teno, Naoki
    Masuya, Keiichi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 752 - 766
12345